
Weight-loss, diabetes drugs linked to vision problems in small study
Fox News
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
Some common GLP-1 drugs include Ozempic and Wegovy, which contain semaglutide as the active ingredient, and Mounjaro and Zepbound, which contain tirzepatide. "The story of GLP-1 is still being written — and we are learning something new about these drugs every day." "Most of the vision side effects appear to resolve when the medication is stopped." Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
In the study, nine patients who were using a GLP-1 developed "ophthalmic complications," according to the researchers. The average age of the patients was 57.4 years, according to the study findings.